Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 2/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3789047 | 0.82 | TDP2 (0.35) | NSD2TTRMEN1KMT2ATDP2 | |
| SCHEMBL5587476 | 0.72 | CA12 (0.39) | MEN1KMT2ATSHRMAPK1SMN1; SMN2 | |
| SCHEMBL9627555 | 0.67 | CDC25B (0.57) | MEN1KMT2ASMN1; SMN2ALDH1A1ALOX15 | |
| SCHEMBL13417406 | 0.66 | MCOLN3 (0.36) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL14000306 | 0.65 | TDP2 (0.47) | NSD2MAPK1SMN1; SMN2TDP2ALDH1A1 | |
| SCHEMBL29208407 | 0.63 | CYP2A6 (0.37) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5589836 | 0.63 | PTPN1 (0.33) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL9641989 | 0.63 | CDC25B (0.52) | NSD2MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL5588449 | 0.63 | KMT2A (0.37) | MEN1KMT2ATSHRMAPK1SMN1; SMN2 | |
| SCHEMBL19732381 | 0.61 | HTT (0.38) | NSD2TTRSMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4241080-B1 | METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE | INST NAT SANTE RECH MED (FR) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-3666294-B1 | POROUS OBJECT BASED ON BIOPOLYMERS HAVING A FLEXIBLE PORE SIZE, ITS PREPARATION AND USE THEREOF | Valeopharm GmbH (DE) | 2026-04-29 | — | — | EP | claimed |
| EP-3790536-B1 | NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-3846784-B1 | CONTROLLED DRUG RELEASE FORMULATION | FACHHOCHSCHULE NORDWESTSCHWEIZ (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-4721705-A1 | SPACER FOR CONTROLLED ADMINISTRATION OF AN ACTIVE AGENT | Heraeus Medical GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| WO-2026041516-A1 | RESORBABLE SHEET MATERIAL COMPRISING POROUS COLLAGEN SPONGE AND NANOPARTICLES OR MICROPARTICLES WHICH RELEASE ACTIVE INGREDIENTS IN A CONTROLLED MANNER, USE THEREOF, AND METHOD FOR THE PRODUCTION THEREOF | MD2B LIFESCIENCE GMBH (DE) | 2026-02-26 | — | — | WO | claimed |
| EP-4267115-B1 | NANOSTRUCTURED DELIVERY SYSTEM FOR TUMOR TREATMENT | SMARTDYELIVERY GMBH (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-3393480-B1 | NUCLEIC ACID OLIGOMERS AND USES THEREFOR | REPLUCA PTY LTD (AU) | 2025-11-12 | — | — | EP | claimed |
| EP-4608546-A1 | DEVICE FOR THE PRODUCTION OF AN AEROSOL | Olig AG (CH) | 2025-09-03 | — | — | EP | claimed |
| WO-2022248547-A1 | COMPOSITIONS CONTAINING MEMBRANE-FORMING SUBSTANCES FOR THE PREPARATION OF A PUMPING FOAM | PROF4SKIN GMBH (DE) | 2022-12-01 | — | — | WO | claimed |
| EP-2280691-B1 | crystalline DOPC | MERCK PATENT GMBH (DE) | 2022-08-03 | — | — | EP | claimed |
| WO-2022157148-A1 | PROCESS FOR PREPARING A DRUG CARRIER, DRUG CARRIER, MATERIAL KIT AND USE OF A DRUG CARRIER | Medical Products Solution GmbH (DE) | 2022-07-28 | — | — | WO | claimed |
| EP-4031863-A1 | IN VITRO USE OF A KIT AND A METHOD FOR DIAGNOSING TRANSPLANTATIONS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS AND ALSO A MESSENGER SUBSTANCE-CONTAINING SUPERNATANT, CELL-CONTAINING SEDIMENT AND A COMBINATION FOR USE IN DIAGNOSING TRANSPLANTATIONS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS | HOT Screen GmbH (DE) | 2022-07-27 | — | — | EP | claimed |
| WO-2022129616-A2 | MOLECULAR SENSOR | Vermes Microdispensing GmbH (DE) | 2022-06-23 | — | — | WO | claimed |
| US-20220118047-A1 | METHOD OF TREATING GLIOBLASTOMA | LANTMÄNNEN AS-FAKTOR AB (SE) | 2022-04-21 | — | — | US | claimed |
| EP-3583421-B1 | NOVEL IN VITRO SYSTEM FOR PREDICTING THE EFFICACY OF DRUG COMBINATIONS IN TUMOR CELLS OR OTHER TARGET CELLS | KISCHKEL FRANK CHRISTIAN (DE) | 2022-02-09 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |